Literature DB >> 24431935

Does the presence of an implant including expander with internal port alter radiation dose? An ex vivo model.

Barbara Strang1, Kyla Murphy2, Shane Seal3, Arianna Dal Cin4.   

Abstract

BACKGROUND: There is a lack of literature examining the dosimetric implications of irradiating breast implants and expanders with internal ports inserted at the time of mastectomy.
OBJECTIVE: To determine whether the presence of breast expanders with port in saline or silicone implants affect the dose uniformity across the breast when irradiated with various photon and electron energies.
METHODS: One tissue-equivalent torso phantom with overlying tissue expanders in saline or silicone implants were irradiated using tangential fields with 6 MV and 18 MV photons and 9 MeV and 12 MeV electrons. All dose measurements were performed using thermoluminescent dosimeters (TLDs). The TLDs were arranged around the port and the perimeters of either the expander, or saline or silicone implant. Comparisons of measured radiation doses, and between the expected and measured doses of radiation from the TLDs on each prosthesis, were performed. Data were analyzed using two-tailed t tests.
RESULTS: There were no differences in TLD measurements between the expander and the saline implant for all energy modalities, and for the expected versus actual measurements for the saline implant. Higher than anticipated measurements were recorded for a significant number of TLD positions around the silicone implants.
CONCLUSIONS: Radiation doses around saline implants or expanders with internal port were unaltered, whereas dose recordings for silicone implants were higher than predicted in the present laboratory/ex vivo study.

Entities:  

Keywords:  Dosimetry; Implants; Radiation

Year:  2013        PMID: 24431935      PMCID: PMC3891098          DOI: 10.1177/229255031302100109

Source DB:  PubMed          Journal:  Can J Plast Surg        ISSN: 1195-2199


  10 in total

1.  Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  A Recht; S B Edge; L J Solin; D S Robinson; A Estabrook; R E Fine; G F Fleming; S Formenti; C Hudis; J J Kirshner; D A Krause; R R Kuske; A S Langer; G W Sledge; T J Whelan; D G Pfister
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

2.  Dosimetry around metallic ports in tissue expanders in patients receiving postmastectomy radiation therapy: an ex vivo evaluation.

Authors:  Janaki Moni; Maria Graves-Ditman; Paul Cederna; Kent Griffith; Editha A Krueger; Benedick A Fraass; Lori J Pierce
Journal:  Med Dosim       Date:  2004       Impact factor: 1.482

3.  Investigation into dosimetric effect of a MAGNA-SITE tissue expander on post-mastectomy radiotherapy.

Authors:  Rosemary C A Thompson; Andrew M Morgan
Journal:  Med Phys       Date:  2005-06       Impact factor: 4.071

4.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.

Authors:  J Ragaz; S M Jackson; N Le; I H Plenderleith; J J Spinelli; V E Basco; K S Wilson; M A Knowling; C M Coppin; M Paradis; A J Coldman; I A Olivotto
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

5.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

6.  Do metallic ports in tissue expanders affect postmastectomy radiation delivery?

Authors:  Shari Damast; Kathryn Beal; Ase Ballangrud; Thomas J Losasso; Peter G Cordeiro; Joseph J Disa; Linda Hong; Beryl L McCormick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-01       Impact factor: 7.038

7.  Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.

Authors:  Marie Overgaard; Hanne M Nielsen; Jens Overgaard
Journal:  Radiother Oncol       Date:  2007-02-15       Impact factor: 6.280

8.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

Authors:  M Overgaard; P S Hansen; J Overgaard; C Rose; M Andersson; F Bach; M Kjaer; C C Gadeberg; H T Mouridsen; M B Jensen; K Zedeler
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

9.  Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.

Authors:  Pauline T Truong; Ivo A Olivotto; Timothy J Whelan; Mark Levine
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

10.  Examination of Jeltrate Plus as a tissue equivalent bolus material.

Authors:  Steven Babic; Andrew T Kerr; Mary Westerland; Jim Gooding; L John Schreiner
Journal:  J Appl Clin Med Phys       Date:  2002       Impact factor: 2.102

  10 in total
  4 in total

1.  Dosimetric analysis of the effects of a temporary tissue expander on the radiotherapy technique.

Authors:  So Hyun Park; Young Suk Kim; Jinhyun Choi
Journal:  Radiol Med       Date:  2020-10-06       Impact factor: 3.469

2.  Magnitude and dosimetric impact of inter-fractional positional variations of the metal port of tissue expanders in postmastectomy patients treated with radiation.

Authors:  Keren Mayorov; Elsayed Ali
Journal:  Phys Imaging Radiat Oncol       Date:  2020-10-13

3.  Robustness of three external beam treatment techniques against inter-fractional positional variations of the metal port in breast tissue expanders.

Authors:  Keren Mayorov; Patricia Lacasse; Elsayed Ali
Journal:  J Appl Clin Med Phys       Date:  2021-11-22       Impact factor: 2.102

4.  Modeling of the metallic port in breast tissue expanders for photon radiotherapy.

Authors:  Jihyung Yoon; Yibo Xie; David Heins; Rui Zhang
Journal:  J Appl Clin Med Phys       Date:  2018-03-30       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.